Most Recent
The director of a documentary about a US narcotics officer during the 1990s 'war on drugs' has won his copyright suit against the film's producers, with a judge finding his moral rights under the Copyright Act were infringed by their failure to credit him as the director.
Bayer and Teva have lost their challenge to Indian drug maker Cipla’s extension of its patent for an allergy medication, with IP Australia finding a failure to pay renewal fees on time was due to a genuine error.
Litigation funder ILP, which has sought an injunction to stop tech investor CPC from terminating their agreement for failure to pay legal fees in its patent case against Apple, has rejected claims it is "hedging its bets".
An April trial date in a high-stakes IP fight between real estate data company BCI and US analytics firm CoreLogic over alleged data scraping is in danger amid a fight about accounting evidence.
An oversight in a trade secrets fight between telcos SPN and Pennytel means the matter was never formally dismissed, making Pennytel's appeal premature in a set of circumstances a judge has described as a "joke".
The operator of Hunter Valley's luxury Elysia Retreat, which has filed an intellectual property suit against the newly established Elysium Hotel in Noosa, has told a court the hotel's trade mark should be removed from the register.
Two units of Queensland real estate firm Coronis have lost a fight with the tax office over service fee deductions claimed for payments to related entities for the use of the Coronis trade mark, among other trust assets.
CIMIC faces a cross-claim in its trade mark infringement case against developer Leyton Property, which wants the building giant's Leighton marks removed from the registry for non-use.
AstraZeneca has won an interlocutory injunction barring Pharmacor from making a generic version of its blockbuster diabetes drug Forxiga while a patent case over the drug proceeds.
The start-up behind Hungry Jack's plant-based 'Rebel Whopper' wants a court to review IP Australia's decision that a proposed patent covering its fake meat product didn't pass muster.